.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Etoposide - Generic Drug Details

« Back to Dashboard
Etoposide is the generic ingredient in four branded drugs marketed by Teva Parenteral, Accord Hlthcare, Pierre Fabre, Hospira, Pharmachemie Bv, Watson Labs, Teva Pharms Usa, Mylan, Dava Pharms Inc, Watson Labs Inc, Corden Pharma, Fresenius Kabi Usa, West-ward Pharms Int, and Bristol Myers Squibb, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for etoposide. Five suppliers are listed for this compound.

Summary for Generic Name: etoposide

Tradenames:4
Patents:0
Applicants:14
NDAs:18
Drug Master File Entries: see list11
Suppliers / Packaging: see list5
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: etoposide

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
ETOPOSIDE
etoposide
INJECTABLE;INJECTION074228-001Oct 15, 1996DISCNNo► subscribe► subscribe
Accord Hlthcare
ETOPOSIDE
etoposide
INJECTABLE;INJECTION074513-001Mar 14, 1996RXNo► subscribe► subscribe
Hospira
ETOPOSIDE
etoposide
INJECTABLE;INJECTION074351-001Aug 30, 1995DISCNNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: etoposide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Corden Pharma
VEPESID
etoposide
INJECTABLE;INJECTION018768-001Nov 10, 19833,524,844► subscribe
Dava Pharms Inc
VEPESID
etoposide
CAPSULE;ORAL019557-002Dec 30, 19863,524,844► subscribe
Dava Pharms Inc
VEPESID
etoposide
CAPSULE;ORAL019557-001Dec 30, 19863,524,844► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc